Ana S. Correia

ULS Matosinhos
Matosinhos, PT 
ULS Matosinhos
Matosinhos, PT 

Overview

Ana Correia practices practicing medicine in Matosinhos, Portugal.

Her clinical expertise encompasses Multiple Sclerosis (MS), Cardiomyopathy, Relapsing Multiple Sclerosis (RMS), and Endocardial Fibroelastosis.

She is actively involved in clinical research, co-authoring 42 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

ULS Matosinhos
Matosinhos, 4464513, Portugal

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Oral CLADribine in Patients That Change From First-line Disease Modifying Treatments for Multiple Sclerosis: a pROspective effectivenesS and Safety Study (CLAD CROSS)
Oral CLADribine in Patients That Change From First-line Disease Modifying Treatments for Multiple Sclerosis: a pROspective effectivenesS and Safety Study (CLAD CROSS)
Enrollment Status: Completed
Publish Date: June 24, 2025
Intervention Type: Drug
Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients With Relapsing Remitting Multiple Sclerosis (MS) Transitioning From Current Subcutaneous Interferon Therapy to Peginterferon Beta 1a (PLEGRIDY™)
Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients With Relapsing Remitting Multiple Sclerosis (MS) Transitioning From Current Subcutaneous Interferon Therapy to Peginterferon Beta 1a (PLEGRIDY™)
Enrollment Status: Completed
Publish Date: November 25, 2020
Intervention Type: Drug
Study Phase: Phase 4
View 1 Less Clinical Trial

42 Total Publications

Fabry Disease Screening in Patients with Idiopathic HCM or LVH: Data from the Multicentric Nationwide F-CHECK Study.
Fabry Disease Screening in Patients with Idiopathic HCM or LVH: Data from the Multicentric Nationwide F-CHECK Study.
Journal: Biomedicines
Published: September 10, 2025

Frequently Asked Questions about Ana S. Correia

Is Ana S. Correia a top-rated expert for Multiple Sclerosis (MS)?

MediFind is an objective health platform that identifies experts based on real-world data. Ana S. Correia is classified as an Experienced expert for Multiple Sclerosis (MS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ana S. Correia participate in research or clinical trials?

Yes. Ana S. Correia has published 42 articles and abstracts on conditions like Multiple Sclerosis (MS). You can view a list of Ana S. Correia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Correia's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile